The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 237 of the 241 references it cites were found in a registry or an index.
Abstract
Objective: To develop clinical practice guidelines for the management of patients with primary aldosteronism. Participants: The Task Force included a chair, selected by the Clinical Guidelines Subcommittee of the Endocrine Society, six additional experts, a methodologist, and a medical writer. The guideline was cosponsored by American Heart Association, American Association of Endocrine Surgeons, European Society of Endocrinology, European Society of Hypertension, International Association of Endocrine Surgeons, International Society of Endocrinology, International Society of Hypertension, Japan Endocrine Society, and The Japanese Society of Hypertension. The Task Force received no corporate funding or remuneration. Evidence: We searched for systematic reviews and primary studies to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation group criteria to describe both the quality of evidence and the strength of recommendations. We used “recommend” for strong recommendations and “suggest” for weak recommendations. Consensus Process: We achieved consensus by collecting the best available evidence and conducting one group meeting, several conference calls, and multiple e-mail communications. With the help of a medical writer, the Endocrine Society's Clinical Guidelines Subcommittee, Clinical Affairs Core Committee, and Council successfully reviewed the drafts prepared by the Task Force. We placed the version approved by the Clinical Guidelines Subcommittee and Clinical Affairs Core Committee on the Endocrine Society's website for comments by members. At each stage of review, the Task Force received written comments and incorporated necessary changes. Conclusions: For high-risk groups of hypertensive patients and those with hypokalemia, we recommend case detection of primary aldosteronism by determining the aldosterone-renin ratio under standard conditions and recommend that a commonly used confirmatory test should confirm/exclude the condition. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend that an experienced radiologist should establish/exclude unilateral primary aldosteronism using bilateral adrenal venous sampling, and if confirmed, this should optimally be treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia or those unsuitable for surgery should be treated primarily with a mineralocorticoid receptor antagonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Algorithm for the detection, confirmation, subtype testing, and treatment of PA. a We recommend unilateral laparoscopic adrenalectomy for patients with documented unilateral PA (ie, APA or UAH) (1 ⎪ QQQE ). If a patient is unable or unwilling to undergo surgery, we recommend medical treatment including a MR antagonist (1 ⎪ QQQE ). If an ARR-positive patient is unwilling or unable to undergo further investigations, we similarly recommend medical treatment including an MR antagonist (1 ⎪ QQEE ). b Instead of proceeding directly to subtype classification, we recommend that patients with a positive ARR undergo one or more confirmatory tests to definitively confirm or exclude the diagnosis (1 ⎪ QQEE ). However, in the setting of spontaneous hypokalemia, undetectable renin, and PAC > 20 ng/dL (550 pmol/L), we suggest that there may be no need for further confirmatory testing (2 ⎪ QEEE ). c We recommend that when surgical treatment is feasible and desired by the patient, an experienced radiologist should use AVS to make the distinction between unilateral and bilateral adrenal disease (1 ⎪ QQQE ). Younger patients ( < age 35) with spontaneous hypokalemia, marked aldosterone excess, and unilateral adrenal lesions with radiological features consistent with a cortical adenoma on adrenal CT scan may not need AVS before proceeding to unilateral adrenalectomy (2 ⎪ QEEE ). [Adapted from J. W. Funder et al: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab . 2008;93:3266-3281 (3), with permission. © Endocrine Society.]](https://figures.cochat.ai/paper-figures/aaade82f5c4b425bbdee69e74321806d/the-management-of-primary-aldosteronism-case-detection-diagnosis-and-treatment-figure-1.png)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common types of secondary hypertension in adults are renal parenchymal disease, renovascular hypertension, primary aldosteronism, chronic sleep apnea, and substance/drug-induced.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A specific cause of secondary hypertension can be identified in 5%-10% of hypertensive patients (Table 11).”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early diagnosis of secondary hypertension and the institution of appropriate targeted treatment have the potential to cure hypertension in some patients or improve BP control/reduce the number of prescribed antihypertensive medications in others.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypokalemia, which reduces aldosterone secretion, should be corrected with oral K+ supplements before testing.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [289]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with unilateral disease (50%; aldosterone-producing adenoma or, much less frequently, unilateral hyperplasia) respond to unilateral laparoscopic adrenalectomy with complete cure (≈50%) or improvement (≈50%) in BP control.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [289]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“The Task Force followed the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation group, an international group with expertise in the development and implementation of evidence-based guidelines (2).”
MethodNational High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) · PEDIATRICS · doi:10.1542/peds.114.2.s2.555 · Cited by 6,938
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
(2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00002 · Cited by 2,672
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554 · cited 3×
“The recommendations and suggestions made by the Task Force were subject to extensive consultation before being published in the Journal of Clinical Endocrinology and Metabolism in 2008 (3).”
MethodSelf-citationEvidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547 · cited 2×
“Several outcome studies also have provided evidence that PA patients are particularly at risk of cardiovascular/ renal complications, including arrhythmias, myocardial infarction, strokes, chronic kidney disease, and death, compared with age-, sex-, and BP-matched essential hypertensives (30, 33, 156).”
BackgroundResultA prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467 · cited 2×
“However, some groups have suggested that when clinicians administer a bolus injection of cosyntropin and sample the adrenal veins simultaneously, cosyntropin does not improve the diagnostic accuracy of AVS, and, in fact, cosyntropin may increase secretion from the nonadenomatous gland to a greater degree than from the…”
BackgroundSelf-citationLifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
K + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
Choi, M., Scholl, U. I., Yue, P., Björklund, P., Zhao, B., Nelson-Williams, C., Ji, W., Cho, Y., Patel, A., Men, C. J., et al. (2011) · Science · doi:10.1126/science.1198785 · Cited by 1,004
Mulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Self-citationPresidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.
Conn, J. W. (1955) · PubMed · Cited by 955
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 855
Self-citationIncidentally Discovered Adrenal Masses*
KLOOS, R. T., GROSS, M. D., FRANCIS, I. R., KOROBKIN, M., & SHAPIRO, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 828
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Role for adrenal venous sampling in primary aldosteronism
Young, W. F., Stanson, A. W., Thompson, G. B., Grant, C. S., Farley, D. R., & van Heerden, J. A. (2004) · Surgery · doi:10.1016/j.surg.2004.06.051 · Cited by 735 · cited 9×
“On the basis of CT findings, 42 patients (22%) would have been incorrectly excluded as candidates for adrenalectomy, and 48 (25%) might have had unnecessary or inappropriate surgery (76).”
BackgroundMethodInfluentialSelf-citationPrimary aldosteronism: renaissance of a syndrome
Young, W. F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02775.x · Cited by 680 · cited 3×
“Aldosterone-producing adrenal carcinomas are almost always 4 cm in diameter, but occasionally smaller, and like most adrenocortical carcinomas have a suspicious imaging phenotype on CT (51, 74).”
BackgroundSelf-citationPrevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
Scholl, U. I., Goh, G., Stölting, G., de Oliveira, R. C., Choi, M., Overton, J. D., Fonseca, A. L., Korah, R., Starker, L. F., Kunstman, J. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2695 · Cited by 627 · cited 3×
“In addition, Scholl et al (147) reported de novo (ie, not inherited) but germline mutations in CACNA1D in two children with a previously undescribed syndrome featuring PA and neuromuscular abnormalities.”
BackgroundRossi, G. P., Auchus, R. J., Brown, M., Lenders, J. W. M., Naruse, M., Plouin, P. F., Satoh, F., & Young, W. F. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02097 · Cited by 613 · cited 3×
“Some investigators consider a cortisol-corrected aldosterone lateralization ratio (high to low side) of more than 2:1 in the absence of cosyntropin as consistent with unilateral disease (88, 104, 108).”
BackgroundSelf-citationBeuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577 · cited 4×
“However, in contrast with patients with somatic KCNJ5 mutations, ATPase mutations are more common in males (146).”
BackgroundInfluentialSelf-citationSerum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033263 · Cited by 571 · cited 1×
“The Framingham Offspring Study suggested the involvement of aldosterone in the development of arterial hypertension in the general population, in which plasma aldosterone levels in normotensive subjects predicted subsequent increases in BP and the development of hypertension (157).”
BackgroundCardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
Catena, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.33 · Cited by 565 · cited 1×
“Several outcome studies also have provided evidence that PA patients are particularly at risk of cardiovascular/ renal complications, including arrhythmias, myocardial infarction, strokes, chronic kidney disease, and death, compared with age-, sex-, and BP-matched essential hypertensives (30, 33, 156).”
ResultSomatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension
Azizan, E. A. B., Poulsen, H., Tuluc, P., Zhou, J., Clausen, M. V., Lieb, A., Maniero, C., Garg, S., Bochukova, E. G., Zhao, W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2716 · Cited by 544 · cited 1×
“CACNA1D gene Two jointly published studies from the United States and the United Kingdom reported somatic mutations in a gene (CACNA1D) encoding a voltage-gated calcium channel (147, 148).”
BackgroundNishikawa, T., Omura, M., Satoh, F., Shibata, H., Takahashi, K., Tamura, N., & Tanabe, A. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0133 · Cited by 534
Self-citationFarquharson, C. A. J., & Struthers, A. D. (2000) · Circulation · doi:10.1161/01.cir.101.6.594 · Cited by 532 · cited 1×
“It lacks the sex steroid-related side effects of spironolactone but does not provide the beneficial effects on endothelial function (195, 196).”
BackgroundKempers, M. J. E., Lenders, J. W. M., van Outheusden, L., van der Wilt, G. J., Schultze Kool, L. J., Hermus, A. R. M. M., & Deinum, J. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-5-200909010-00007 · Cited by 510 · cited 1×
“Accuracy of CT and MRI in diagnosing laterality of aldosterone secretion (adrenal vein sampling is the “gold standard”) (7) Diagnostic accuracy outcome: in 37.”
BackgroundHIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION
Gordon, R. D., Stowasser, M., Tunny, T. J., Klemm, S. A., & Rutherford, J. C. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02519.x · Cited by 496 · cited 1×
“Cross-sectional and prospective studies report PA in (cid:2) 5% and possibly (cid:2) 10% of hypertensive patients, both in general and in specialty settings (6, 19–29).”
BackgroundSelf-citationPrimary Aldosteronism and Hypertensive Disease
Mosso, L., Carvajal, C., González, A., Barraza, A., Avila, F., Montero, J., Huete, A., Gederlini, A., & Fardella, C. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000079505.25750.11 · Cited by 488 · cited 2×
“Moderate/severe hypertension: the prevalence rates cited here are from Mosso et al (27).”
BackgroundFardella, C. E., Mosso, L., Gómez-Sánchez, C., Cortés, P., Soto, J., Gómez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6596 · Cited by 463 · cited 2×
“We based the classification of BP for adults (aged 18 y) on the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (207), which establishes three different stages: Stage 1 SBP 140–159 mm Hg, DBP 90–99 mm Hg; Stage 2 SBP 160–179 mm Hg, DBP 100–109 mm…”
BackgroundMethodDrug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism
Mulatero, P., Rabbia, F., Milan, A., Paglieri, C., Morello, F., Chiandussi, L., & Veglio, F. (2002) · Hypertension · doi:10.1161/01.hyp.0000038478.59760.41 · Cited by 392
Guo, F., He, D., Zhang, W., & Walton, R. G. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.026 · Cited by 391
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
Weinberger, M. H., Roniker, B., Krause, S. L., & Weiss, R. J. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02957-6 · Cited by 388 · cited 1×
“hypertension (190, 191) in the United States and Japan,”
BackgroundMinireview: Primary Aldosteronism—Changing Concepts in Diagnosis and Treatment
Young, W. F. (2003) · Endocrinology · doi:10.1210/en.2003-0279 · Cited by 376
Self-citationRossi, G. P., Barisa, M., Allolio, B., Auchus, R. J., Amar, L., Cohen, D., Degenhart, C., Deinum, J., Fischer, E., Gordon, R., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2830 · Cited by 369 · cited 1×
“At centers with experienced AVS radiologists, the complication rate is 2.5% or lower (76, 78, 103).”
BackgroundInfluentialSelf-citationCatena, C., Colussi, G., Lapenna, R., Nadalini, E., Chiuch, A., Gianfagna, P., & Sechi, L. A. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.095448 · Cited by 358 · cited 3×
“Our recommendation also places a high value on avoiding the risk associated with missing a diagnosis of unilateral forms of PA and thus the opportunity of possibly curative intervention by unilateral adrenalectomy leading to the reduction or complete cessation of antihypertensive medications (39) and the reduction of…”
BackgroundInfluentialRossi, G. P., Cesari, M., Cuspidi, C., Maiolino, G., Cicala, M. V., Bisogni, V., Mantero, F., & Pessina, A. C. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01316 · Cited by 356 · cited 5×
“…adrenalectomy leading to the reduction or complete cessation of antihypertensive medications (39) and the reduction of target organ damage (32, 36, 40), and it places a lower value on avoiding the risks of exposing patients with bilateral PA (who are rarely candidates for surgical…”
BackgroundInfluentialSelf-citationHiramatsu, K. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.12.1589 · Cited by 355
Primary Aldosteronism: Diagnosis, Localization, and Treatment
WEINBERGER, M. H., GRIM, C. E., HOLLIFIELD, J. W., KEM, D. C., GANGULY, A., KRAMER, N. J., YUNE, H. Y., WELLMAN, H., & DONOHUE, J. P. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-3-386 · Cited by 352 · cited 2×
“For continuous cosyntropin, clinicians should begin an infusion of 50 g/h of cosyntropin 30 minutes before adrenal vein catheterization and continue it throughout the procedure (76, 84, 90).”
MethodPrimary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery
Sawka, A. M., Young, W. F., Thompson, G. B., Grant, C. S., Farley, D. R., Leibson, C., & van Heerden, J. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-4-200108210-00010 · Cited by 347 · cited 4×
“Distinguishing between unilateral and bilateral disease is important because unilateral adrenalectomy in all patients with APA or UAH results in the normalization of hypokalemia; hypertension is also improved in all and cured in 30–60% of these patients (32, 44, 80, 81).”
BackgroundInfluentialSelf-citationPrevalence of Primary Aldosteronism among Asian Hypertensive Patients in Singapore1
Loh, K.-C., Koay, E. S., Khaw, M.-C., Emmanuel, S. C., & Young, W. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6752 · Cited by 345
Self-citationThree new epoxy-spirolactone derivatives: characterization in vivo and in vitro.
de Gasparo, M., Joss, U., Ramjoué, H. P., Whitebread, S. E., Haenni, H., Schenkel, L., Kraehenbuehl, C., Biollaz, M., Grob, J., & Schmidlin, J. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22580-0 · Cited by 343 · cited 1×
“Eplerenone Eplerenone is a newer, selective MR antagonist without antiandrogen and progesterone agonist effects (189), thus”
BackgroundHannemann, A., & Wallaschofski, H. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1295438 · Cited by 340 · cited 1×
“Prevalence of PA (6) Weighted mean prevalence of elevated ARRs and PA in primary care (prevalence of high ARRs, 16.”
BackgroundWilcox, R. G. (1995) · BMJ · doi:10.1136/bmj.310.6979.609 · Cited by 335
Hiramatsu, K. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340130033011 · Cited by 334 · cited 1×
“…design of studies that have addressed this issue) (8), numerous studies have demonstrated the ARR to be superior in measuring potassium or aldosterone (both of which have lower sensitivity) or renin (which is less specific) in isolation (39, 41, 42).”
BackgroundChanges in Left Ventricular Anatomy and Function in Hypertension and Primary Aldosteronism
Rossi, G. P., Sacchetto, A., Visentin, P., Canali, C., Graniero, G. R., Palatini, P., & Pessina, A. C. (1996) · Hypertension · doi:10.1161/01.hyp.27.5.1039 · Cited by 328
Adrenal Vein Sampling: How to Make It Quick, Easy, and Successful
Daunt, N. (2005) · RadioGraphics · doi:10.1148/rg.25si055514 · Cited by 315 · cited 3×
“Catheterization Clinicians (commonly interventional radiologists) catheterize the adrenal veins using the percutaneous femoral vein approach and verify the position of the catheter tip by radiography after injecting a small amount of nonionic contrast medium (78, 111).”
BackgroundDiagnosis and Treatment of Primary Hyperaldosteronism
Blumenfeld, J. D., Sealey, J. E., Schlussel, Y., Vaughan, E. D., Sos, T. A., Atlas, S. A., Muller, F. B., Acevedo, R., Ulick, S., & Laragh, J. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-11-199412010-00010 · Cited by 308
Gallay, B. J., Ahmad, S., Xu, L., Toivola, B., & Davidson, R. C. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80117-7 · Cited by 304 · cited 1×
“The lack of uniformity in diagnostic protocols and assay methods for measuring the ARR has been associated with substantial variability in cutoff values (24–26, 53– 56).”
BackgroundSwiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302 · cited 1×
“A detailed description of this grading scheme has been published elsewhere (4).”
MethodSelf-citationFardella, C. E. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1863 · Cited by 298
A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism
Geller, D. S., Zhang, J., Wisgerhof, M. V., Shackleton, C., Kashgarian, M., & Lifton, R. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0594 · Cited by 296 · cited 1×
“pertensive therapy, requiring bilateral adrenalectomy (138).”
Rossi, G. P. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1083 · Cited by 289 · cited 2×
“expensive and invasive, and so it is highly desirable to avoid this test in patients who do not have PA (88).”
BackgroundParthasarathy, H. K., Ménard, J., White, W. B., Young, W. F., Williams, G. H., Williams, B., Ruilope, L. M., McInnes, G. T., Connell, J. M., & MacDonald, T. M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283455ca5 · Cited by 281 · cited 2×
“enone in the medical treatment of PA (178).”
BackgroundSelf-citationStowasser, M., Gordon, R. D., Gunasekera, T. G., Cowley, D. C., Ward, G., Archibald, C., & Smithers, B. M. (2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00025 · Cited by 280
Self-citationResistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy
Goodfriend, T. L., & Calhoun, D. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000116223.97436.e5 · Cited by 279
Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism
Boulkroun, S., Beuschlein, F., Rossi, G.-P., Golib-Dzib, J.-F., Fischer, E., Amar, L., Mulatero, P., Samson-Couterie, B., Hahner, S., Quinkler, M., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.186478 · Cited by 278
Self-citationObservational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry
Reincke, M., Fischer, E., Gerum, S., Merkle, K., Schulz, S., Pallauf, A., Quinkler, M., Hanslik, G., Lang, K., Hahner, S., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.197111 · Cited by 278 · cited 4×
“Recently, however, a large case-control study demonstrated a similar mortality of patients with PA treated with either adrenalectomy or MR antagonists compared with mortality of patients with essential (primary) hypertension (33).”
BackgroundResultInfluentialSelf-citationEfficacy and tolerance of spironolactone in essential hypertension
Jeunemaitre, X., Chatellier, G., Kreft-Jais, C., Charru, A., Devries, C., Plouin, P.-F., Corvol, P., & Menard, J. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91030-7 · Cited by 276 · cited 1×
“9% at a dose 50 mg/d and 52% at a dose 150 mg/d (188).”
Stowasser, M., Sharman, J., Leano, R., Gordon, R. D., Ward, G., Cowley, D., & Marwick, T. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0681 · Cited by 271 · cited 2×
“Why is primary aldosteronism important? This condition is important not only because of its prevalence, but also because patients with PA have higher cardiovascular morbidity and mortality than age- and sexmatched patients with essential hypertension and the same degree of BP elevation (30, 31).”
BackgroundSelf-citationHigh prevalence of primary aldosteronism in the Tayside hypertension clinic population
Lim, P., Dow, E., Brennan, G., Jung, R., & MacDonald, T. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001013 · Cited by 269 · cited 1×
“The lack of uniformity in diagnostic protocols and assay methods for measuring the ARR has been associated with substantial variability in cutoff values (24–26, 53– 56).”
BackgroundIncidentally discovered adrenal masses
Kloos, R. T. (1995) · Endocrine Reviews · doi:10.1210/er.16.4.460 · Cited by 267
Prevalence of primary and secondary hypertension: studies in a random population sample.
Berglund, G., Andersson, O., & Wilhelmsen, L. (1976) · BMJ · doi:10.1136/bmj.2.6035.554 · Cited by 266
Low-renin status in therapy-resistant hypertension: a clue to efficient treatment
Eide, I. K., Torjesen, P. A., Drolsum, A., Babovic, A., & Lilledahl, N. P. (2004) · Journal of Hypertension · doi:10.1097/00004872-200411000-00026 · Cited by 265 · cited 1×
“Although less efficacious than spironolactone (193, 194), amiloride does have some advantages.”
BackgroundAldosterone Excretion Among Subjects With Resistant Hypertension and Symptoms of Sleep Apnea
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., & Harding, S. M. (2004) · Chest · doi:10.1378/chest.125.1.112 · Cited by 260
Scholl, U. I., Nelson-Williams, C., Yue, P., Grekin, R., Wyatt, R. J., Dillon, M. J., Couch, R., Hammer, L. K., Harley, F. L., Farhi, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121407109 · Cited by 259 · cited 1×
“In one study of four families with FH-III, nine of 10 affected subjects were diagnosed at age 6 or younger, with half undergoing bilateral adrenalectomy for uncontrolled PA (140).”
BackgroundSecondary Hypertension in a Blood Pressure Clinic
Sinclair, A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.7.1289 · Cited by 248
Adrenal Venous Sampling: Evaluation of the German Conn's Registry
Vonend, O., Ockenfels, N., Gao, X., Allolio, B., Lang, K., Mai, K., Quack, I., Saleh, A., Degenhart, C., Seufert, J., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168484 · Cited by 246 · cited 1×
“With experience, the success rate increases to 90–96% (76, 78, 79, 90, 91).”
BackgroundSelf-citationNormokalemic Primary Aldosteronism: A Detectable Cause of Curable "Essential" Hypertension
Conn, J. W. (1965) · JAMA · doi:10.1001/jama.1965.03090030022005 · Cited by 244
Štrauch, B., Zelinka, T., Hampf, M., Bernhardt, R., & Widimsky, J. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001554 · Cited by 237 · cited 1×
“Others have reported similar estimates (28, 67, 163, 206).”
ResultRossi, G. P., Bolognesi, M., Rizzoni, D., Seccia, T. M., Piva, A., Porteri, E., Tiberio, G. A. M., Giulini, S. M., Agabiti-Rosei, E., & Pessina, A. C. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.111369 · Cited by 232 · cited 1×
“Either unilateral adrenalectomy or MR antagonist therapy can reverse the cardiovascular morbidity caused by aldosterone excess (158).”
BackgroundGuo, T., Taylor, R. L., Singh, R. J., & Soldin, S. J. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.03.034 · Cited by 227
Burton, T. J., Mackenzie, I. S., Balan, K., Koo, B., Bird, N., Soloviev, D. V., Azizan, E. A. B., Aigbirhio, F., Gurnell, M., & Brown, M. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1537 · Cited by 226
Schwartz, G. L., & Turner, S. T. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.041780 · Cited by 221 · cited 1×
“Others have reported similar estimates (28, 67, 163, 206).”
ResultPrimary aldosteronism: diagnostic and treatment strategies
Mattsson, C., & Young, W. F. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0151 · Cited by 219 · cited 2×
“They should also withdraw potassium supplementation on postoperative day 1, discontinue spironolactone, and reduce antihypertensive therapy, if appropriate (175).”
BackgroundInfluentialSelf-citationHyperaldosteronism: sampling the adrenal veins.
Doppman, J. L., & Gill, J. R. (1996) · Radiology · doi:10.1148/radiology.198.2.8596821 · Cited by 218 · cited 4×
“be especially difficult to catheterize because it is short and enters the inferior vena cava at an acute angle (90).”
BackgroundMethodInfluentialYoung, W. F., & Stanson, A. W. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03450.x · Cited by 215 · cited 1×
“Catheterization Clinicians (commonly interventional radiologists) catheterize the adrenal veins using the percutaneous femoral vein approach and verify the position of the catheter tip by radiography after injecting a small amount of nonionic contrast medium (78, 111).”
BackgroundSelf-citationReliability of screening methods for the diagnosis of primary aldosteronism
Streeten, D. H. P., Tomycz, N., & Anderson, G. H. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90786-1 · Cited by 214
Lafferty, A. R., Torpy, D. J., Stowasser, M., Taymans, S. E., Lin, J. P., Huggard, P., Gordon, R. D., & Stratakis, C. A. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.11.831 · Cited by 212 · cited 1×
“The molecular basis for FH-II is unclear, although several linkage analyses have shown an association with chromosomal region 7p22 (135, 137).”
BackgroundSelf-citationLim, V., Guo, Q., Grant, C. S., Thompson, G. B., Richards, M. L., Farley, D. R., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4146 · Cited by 208 · cited 1×
“However, in patients younger than 35 years with marked PA (eg, spontaneous hypokalemia; PAC (cid:2) 30 ng/dL, 831 pmol/L) and solitary unilateral apparent adenoma on CT scan, a case can be made to proceed directly to unilateral adrenalectomy without prior AVS (76, 98–101) (Figure 1).”
BackgroundSelf-citationMontori, V. M., & Young, W. F. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00013-0 · Cited by 202 · cited 2×
“Use of ARR as a screening test for PA (8) Diagnostic accuracy estimates not available (due to methodological limitations) 16 Observational studies (3136 patients) (QEEE)”
BackgroundMethodSelf-citationRelative Glomerular Hyperfiltration in Primary Aldosteronism
Ribstein, J., Du Cailar, G., Fesler, P., & Mimran, A. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100878 · Cited by 201 · cited 1×
“Observations suggest that patients with PA may have reversible reduction in intrarenal vascular resistance and glomerular hyperfiltration, which may disguise the underlying renal injury, including declining glomerular filtration rate and albuminuria (40, 197).”
BackgroundMCKENNA, T. J., SEQUEIRA, S. J., HEFFERNAN, A., CHAMBERS, J., & CUNNINGHAM, S. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-952 · Cited by 200
Intracranial Aneurysm and Hemorrhagic Stroke in Glucocorticoid-remediable Aldosteronism
Litchfield, W. R., Anderson, B. F., Weiss, R. J., Lifton, R. P., & Dluhy, R. G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.445 · Cited by 198 · cited 4×
“SomestudiessuggestahighpretestprobabilityforGRA in children or young adults with severe or resistant hypertension and a positive family history of early onset hypertension and/or premature hemorrhagic stroke (129, 130).”
BackgroundInfluentialComparison of Confirmatory Tests for the Diagnosis of Primary Aldosteronism
Mulatero, P., Milan, A., Fallo, F., Regolisti, G., Pizzolo, F., Fardella, C., Mosso, L., Marafetti, L., Veglio, F., & Maccario, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0078 · Cited by 195 · cited 1×
“et al (62, 63), who reported a satisfactory agreement be-”
BackgroundFactors Affecting the Aldosterone/Renin Ratio
Stowasser, M., Ahmed, A., Pimenta, E., Taylor, P., & Gordon, R. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1295460 · Cited by 192 · cited 2×
“Of125patientswhohad APAs removed, 20 (16%) had upright midmorning plasma aldosterone levels of 15 ng/dL, and five (4%) had levels 10 ng/dL (280 pmol/L) (43).”
BackgroundSelf-citationA review of the medical treatment of primary aldosteronism
Lim, P. O., Young, W. F., & MacDonald, T. M. (2001) · Journal of Hypertension · doi:10.1097/00004872-200103000-00001 · Cited by 191 · cited 1×
“Although less efficacious than spironolactone (193, 194), amiloride does have some advantages.”
BackgroundSelf-citationYoung, W. F., & Klee, G. G. (1988) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30425-0 · Cited by 191 · cited 4×
“In a review of 16 published reports, the accuracy of the posture stimulation test was 85% in 246 patients with surgically verified APA (87).”
InfluentialSelf-citationAzizan, E. A. B., Lam, B. Y. H., Newhouse, S. J., Zhou, J., Kuc, R. E., Clarke, J., Happerfield, L., Marker, A., Hoffman, G. J., & Brown, M. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2965 · Cited by 190
Primary aldosteronism—careful investigation is essential and rewarding
Stowasser, M., & Gordon, R. D. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.006 · Cited by 190 · cited 25×
“Most of the data available come from the Brisbane group (39, 52, 53, 89, 112, 226) who have established, on the basis of a very large series of patients, a cutoff of a PAC of 6 ng/dL (170 nmol/L) at 10 AM in an ambulatory patient on day 4.”
BackgroundInfluentialSelf-citationÅkerström, T., Crona, J., Delgado Verdugo, A., Starker, L. F., Cupisti, K., Willenberg, H. S., Knoefel, W. T., Saeger, W., Feller, A., Ip, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041926 · Cited by 188
Phillips, J. L., Walther, M. M., Pezzullo, J. C., Rayford, W., Choyke, P. L., Berman, A. A., Linehan, W. M., Doppman, J. L., & Gill, J. R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4526 · Cited by 187 · cited 1×
“…(consistent with angiotensin II-unresponsive APA or hyperaldosteronism type 1 [FH-I], with the latter readily confirmed or excluded by genetic testing)—may serve an ancillary role, for example, in those patients for whom AVS was unsuccessful and CT shows a unilateral adrenal mass (115, 116).”
BackgroundCampbell, D. J., Nussberger, J., Stowasser, M., Danser, A. H. J., Morganti, A., Frandsen, E., & Ménard, J. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118000 · Cited by 187 · cited 1×
“It should be noted that there is poor correlation between DRC and PRA in the range where PRA is 1 ng/mL/h, the domain of major interest in PA screening (221, 222).”
BackgroundSelf-citationSaline Suppression of Plasma Aldosterone in Hypertension
Kem, D. C. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.1971.00310210056004 · Cited by 180 · cited 1×
“8 ng/ dL (190 pmol/L) has been found to offer the best trade-off between sensitivity and specificity (57, 58, 224, 225).”
BackgroundFactors Influencing Outcome of Surgery for Primary Aldosteronism
Celen, O. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430180072015 · Cited by 179 · cited 5×
“The most common reasons for persistently increased BP after adrenalectomy are coexistent primary hypertension (of unknown cause) (44, 80) and older age and/or longer duration of hypertension.”
BackgroundInfluentialA Clinical Prediction Score to Diagnose Unilateral Primary Aldosteronism
Küpers, E. M., Amar, L., Raynaud, A., Plouin, P.-F., & Steichen, O. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1917 · Cited by 179 · cited 2×
“73 m(2); all had unilateral PA (100% specificity, 95% confidence interval, 91 to 100; and 53% sensitivity, 95% confidence interval, 38 to 68) (71).”
Prevalence of Primary Aldosteronism among Asian Hypertensive Patients in Singapore
Loh, K.-C. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2854 · Cited by 179
Expression and Mutations of KCNJ5 mRNA in Japanese Patients with Aldosterone-Producing Adenomas
Taguchi, R., Yamada, M., Nakajima, Y., Satoh, T., Hashimoto, K., Shibusawa, N., Ozawa, A., Okada, S., Rokutanda, N., Takata, D., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2885 · Cited by 178 · cited 1×
“Since its first publication, large collections of sporadic APAs have been screened worldwide, demonstrating that KCNJ5 mutations are present in 10 to 68% of APAs (142– 145).”
BackgroundFurther evaluation of saline infusion for the diagnosis of primary aldosteronism.
Holland, O. B., Brown, H., Kuhnert, L., Fairchild, C., Risk, M., & Gomez-Sanchez, C. E. (1984) · Hypertension · doi:10.1161/01.hyp.6.5.717 · Cited by 178
Brown, J. J., Davies, D. L., Ferriss, J. B., Fraser, R., Haywood, E., Lever, A. F., & Robertson, J. I. S. (1972) · BMJ · doi:10.1136/bmj.2.5816.729 · Cited by 177
Mulatero, P., Tizzani, D., Viola, A., Bertello, C., Monticone, S., Mengozzi, G., Schiavone, D., Williams, T. A., Einaudi, S., Grotta, A. L., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.175083 · Cited by 172 · cited 1×
“In a recent monocentric prospective study of 199 index cases with PA, systematic screening for FH-II in family members resulted in 12 additional families (6%) with 35 affected members (128).”
BackgroundPrimary Hyperaldosteronism: Effect of Adrenal Vein Sampling on Surgical Outcome
Nwariaku, F. E. (2006) · Archives of Surgery · doi:10.1001/archsurg.141.5.497 · Cited by 171
Resistant hypertension, obstructive sleep apnoea and aldosterone
Dudenbostel, T., & Calhoun, D. A. (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2011.47 · Cited by 168 · cited 1×
“Hypertension with obstructive sleep apnea (217, 218).”
Sukor, N., Kogovsek, C., Gordon, R. D., Robson, D., & Stowasser, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1763 · Cited by 165 · cited 3×
“Two prospective studies also reported the reversal of albuminuria 1 year after adrenalectomy (40, 168), and another study reported significant improvement in quality of life by 3 months sustained at 6 months (38).”
BackgroundSelf-citationTiu, S.-C., Choi, C.-H., Shek, C.-C., Ng, Y.-W., Chan, F. K. W., Ng, C.-M., & Kong, A. P. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1149 · Cited by 164
Rossi, E. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02969-2 · Cited by 164 · cited 3×
“Others have reported similar estimates (28, 67, 163, 206).”
BackgroundResultEditore, S. (2015) · Cited by 159
Gordon, R. D. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349761 · Cited by 158
Giacchetti, G., Ronconi, V., Lucarelli, G., Boscaro, M., & Mantero, F. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000217857.20241.0f · Cited by 154
Self-citationJonsson, J. R., Klemm, S. A., Tunny, T. J., Stowasser, M., & Gordon, R. D. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1225 · Cited by 154 · cited 2×
“Genetic testing by either Southern blot (131) or long PCR (132) techniques for the underlying hybrid CYP11B1/ CYP11B2 mutation is sensitive and specific for GRA and should replace indirect testing (eg, urinary levels of 18oxocortisol and 18-hydroxy-cortisol, or dexamethasone suppression testing), both of which may be…”
MethodSelf-citationLim, Jung, & MacDonald (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00070.x · Cited by 154
Medical Management of Aldosterone-Producing Adenomas
Ghose, R. P., Hall, P. M., & Bravo, E. L. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-2-199907200-00005 · Cited by 150 · cited 1×
“(172), with 83% of these patients requiring additional”
BackgroundBIGLIERI, E. G., SCHAMBELAN, M., HIRAI, J., CHANG, B., & BRUST, N. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-1-87 · Cited by 146 · cited 1×
“levels that are usually less than 100 ng/dL (122).”
BackgroundTanabe, A., Naruse, M., Takagi, S., Tsuchiya, K., Imaki, T., & Takano, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021476 · Cited by 146 · cited 1×
“measurements (68, 69), Letavernier et al (70) consider PA”
BackgroundCLINICAL AND PATHOLOGICAL DIVERSITY OF PRIMARY ALDOSTERONISM, INCLUDING A NEW FAMILIAL VARIETY
Gordon, R. D., Stowasser, M., Tunny, T. J., Klemm, S. A., Finn, W. L., & Krek, A. L. (1991) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1991.tb01446.x · Cited by 146 · cited 1×
“Unlike FH-I, the hyperaldosteronism in FH-II does not suppress with dexamethasone, and GRA mutation testing is negative (136).”
BackgroundSelf-citationSchirpenbach, C., Seiler, L., Maser-Gluth, C., Beuschlein, F., Reincke, M., & Bidlingmaier, M. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068502 · Cited by 146
Self-citationLong-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism
Sywak, M., & Pasieka, J. L. (2002) · British Journal of Surgery · doi:10.1046/j.1365-2168.2002.02261.x · Cited by 142 · cited 1×
“In the long-term, adrenalectomy is more cost-effective than lifelong medical therapy for patients with unilateral PA (173, 174).”
BackgroundEffect of Spironolactone in Hypertensive Patients
Crane, M. G., & Harris, J. J. (1970) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197012000-00001 · Cited by 139
Hypokalemia in the Hypertensive Patient: With Observations on the Incidence of Primary Aldosteronism
KAPLAN, N. M. (1967) · Annals of Internal Medicine · doi:10.7326/0003-4819-66-6-1079 · Cited by 137 · cited 1×
“1% of patients with mild-to-moderate essential hypertension and had assumed that hypokalemia was a sine qua non for diagnosis (12–18).”
BackgroundEspiner, E. A., Ross, D. G., Yandle, T. G., Richards, A. M., & Hunt, P. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022051 · Cited by 137
Intrarenal Hemodynamics in Primary Aldosteronism before and after Treatment
Sechi, L. A., Fabio, A. D., Bazzocchi, M., Uzzau, A., & Catena, C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2245 · Cited by 137 · cited 1×
“Treating PA by adrenalectomy or with an MR antagonist frequently unmasks the underlying reduction in renal function in patients with PA (198, 199).”
BackgroundA survey on incidental adrenal tumors in Japan
Aso, Y., & Homma, Y. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37601-2 · Cited by 136
Bernini, G., Galetta, F., Franzoni, F., Bardini, M., Taurino, C., Bernardini, M., Ghiadoni, L., Bernini, M., Santoro, G., & Salvetti, A. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831286fd · Cited by 136
The evolution of primary aldosteronism: 1954-1967.
Conn, J. W. (1966) · PubMed · Cited by 135
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism
Karagiannis, A., Tziomalos, K., Papageorgiou, A., Kakafika, A. I., Pagourelias, E. D., Anagnostis, P., Athyros, V. G., & Mikhailidis, D. P. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.4.509 · Cited by 133
Mulatero, P., di Cella, S. M., Monticone, S., Schiavone, D., Manzo, M., Mengozzi, G., Rabbia, F., Terzolo, M., Gomez-Sanchez, E. P., Gomez-Sanchez, C. E., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2384 · Cited by 133 · cited 2×
“pected FH-II (after exclusion of FH-I) (123), one family”
BackgroundSubclinical hormone secretion by incidentally discovered adrenal masses
Caplan, R. H. (1994) · Archives of Surgery · doi:10.1001/archsurg.1994.01420270067016 · Cited by 133
Glucocorticoid-Remediable Aldosteronism
McMahon, G. T., & Dluhy, R. G. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000096417.42861.ce · Cited by 130
LAPAROSCOPIC PARTIAL VERSUS TOTAL ADRENALECTOMY FOR ALDOSTERONE PRODUCING ADENOMA
ISHIDOYA, S., ITO, A., SAKAI, K., SATOH, M., CHIBA, Y., SATO, F., & ARAI, Y. (2005) · Journal of Urology · doi:10.1097/01.ju.0000162045.68387.c3 · Cited by 129 · cited 1×
“glands are found to contain multiple nodules (171).”
BackgroundSatoh, F., Morimoto, R., Ono, Y., Iwakura, Y., Omata, K., Kudo, M., Takase, K., Seiji, K., Sasamoto, H., Honma, S., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04453 · Cited by 129 · cited 1×
“More recently, the same group has shown a considerable degree of separation between APA and IHA, with less than 40% of patients not able to be allocated to one or the other on the basis of 18-oxocortisol measurements (125).”
BackgroundIwakura, Y., Morimoto, R., Kudo, M., Ono, Y., Takase, K., Seiji, K., Arai, Y., Nakamura, Y., Sasano, H., Ito, S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2180 · Cited by 126 · cited 1×
“Treating PA by adrenalectomy or with an MR antagonist frequently unmasks the underlying reduction in renal function in patients with PA (198, 199).”
BackgroundInappropriate Left Ventricular Mass in Patients With Primary Aldosteronism
Muiesan, M. L., Salvetti, M., Paini, A., Agabiti-Rosei, C., Monteduro, C., Galbassini, G., Belotti, E., Aggiusti, C., Rizzoni, D., Castellano, M., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114140 · Cited by 126
Racial Differences in Sensitivity of Blood Pressure to Aldosterone
Tu, W., Eckert, G. J., Hannon, T. S., Liu, H., Pratt, L. M., Wagner, M. A., DiMeglio, L. A., Jung, J., & Pratt, J. H. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02989 · Cited by 126
Proye, C. A. G., Mulliez, E., Carnaille, B. M. L., Lecomte-Houcke, M., Decoulx, M., Wemeau, J. L., Lefèbvre, J., Racadot, A., Ernst, O., Huglo, D. G., et al. (1998) · Surgery · doi:10.1067/msy.1998.93108 · Cited by 125
Di Murro, A., Petramala, L., Cotesta, D., Zinnamosca, L., Crescenzi, E., Marinelli, C., Saponara, M., & Letizia, C. (2010) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320310366581 · Cited by 125
Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia
Williams, J. S., Williams, G. H., Raji, A., Jeunemaître, X., Brown, N. J., Hopkins, P. N., & Conlin, P. R. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001948 · Cited by 124 · cited 2×
“Others have reported similar estimates (28, 67, 163, 206).”
BackgroundResultFishman, L. M. (1968) · JAMA · doi:10.1001/jama.205.7.497 · Cited by 124
Seated Saline Suppression Testing For The Diagnosis Of Primary Aldosteronism: A Preliminary Study
Ahmed, A. H., Cowley, D., Wolley, M., Gordon, R. D., Xu, S., Taylor, P. J., & Stowasser, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1153 · Cited by 123 · cited 3×
“diagnosing PA (73), holds promise as a more practical”
BackgroundInfluentialSelf-citationDiagnosis of Secondary Forms of Hypertension
Grim, C. E. (1977) · JAMA · doi:10.1001/jama.237.13.1331 · Cited by 122
Letavernier, E., Peyrard, S., Amar, L., Zinzindohoué, F., Fiquet, B., & Plouin, P.-F. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283060f0c · Cited by 121 · cited 2×
“measurements (68, 69), Letavernier et al (70) consider PA”
BackgroundInfluentialBülow, B., Ahrén, B., & the Swedish Research Council Study Group of Endocrine Abdominal Tumours (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01028.x · Cited by 120
Frequency of Surgical Treatment for Hypertension in Adults at the Mayo Clinic From 1973 Through 1975
Tucker, R. M., & Labarthe, D. R. (1977) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)09888-x · Cited by 120
Location of Aldosterone-Producing Adenomas with131I-19-Iodocholesterol
Hogan, M. J., McRae, J., Schambelan, M., & Biglieri, E. G. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602192940802 · Cited by 119 · cited 1×
“However, the sensitivity of this test depends heavily on the size of the adenoma (119, 120).”
BackgroundMeasurement of Aldosterone in Human Plasma by Semiautomated HPLC–Tandem Mass Spectrometry
Taylor, P. J., Cooper, D. P., Gordon, R. D., & Stowasser, M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.116004 · Cited by 118 · cited 1×
“Published studies have included numerous tandem mass spectrometrymethods thathaveaffordedapathway toassay standardization and improved analytical accuracy (50).”
BackgroundSelf-citationLetavernier, E., Peyrard, S., Amar, L., Zinzindohoue, F., Fiquet, B., & Plouin, P. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328324eb3d · Cited by 116
Conn, J. W. (1972) · Archives of Internal Medicine · doi:10.1001/archinte.1972.00320030037002 · Cited by 115 · cited 1×
“raphy in the early 1970s (117), and an improved agent,”
Rapid Cortisol Assays Improve the Success Rate of Adrenal Vein Sampling for Primary Aldosteronism
Auchus, R. J., Michaelis, C., Wians, F. H., Dolmatch, B. L., Josephs, S. C., Trimmer, C. K., Anderson, M. E., & Nwariaku, F. E. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181961d77 · Cited by 115
Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism.
Baer, L., Sommers, S. C., Krakoff, L. R., Newton, M. A., & LARAGH, J. H. (1970) · PubMed · Cited by 114
Long‐term Follow‐up after Adrenalectomy for Primary Aldosteronism
Meyer, A., Brabant, G., & Behrend, M. (2005) · World Journal of Surgery · doi:10.1007/s00268-004-7496-z · Cited by 112 · cited 3×
“Distinguishing between unilateral and bilateral disease is important because unilateral adrenalectomy in all patients with APA or UAH results in the normalization of hypokalemia; hypertension is also improved in all and cured in 30–60% of these patients (32, 44, 80, 81).”
BackgroundRossi, G. P., Belfiore, A., Bernini, G., Desideri, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mallamaci, F., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328126856e · Cited by 112 · cited 3×
“formed under adequate sodium intake conditions (58), al-”
BackgroundSelf-citationCaptopril Suppression Versus Salt Loading in Confirming Primary Aldosteronism
Agharazii, M., Douville, P., Grose, J. H., & Lebel, M. (2001) · Hypertension · doi:10.1161/01.hyp.37.6.1440 · Cited by 111 · cited 1×
“In patients with PA it remains elevated and PRA remains suppressed (58, 60, 163, 227).”
BackgroundGANGULY, A., DOWDY, A. J., LUETSCHER, J. A., & MELADA, G. A. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-2-401 · Cited by 109 · cited 1×
“change in angiotensin II that occurred with standing (113).”
BackgroundRapid Cortisol Assay during Adrenal Vein Sampling in Patients with Primary Aldosteronism
Mengozzi, G., Rossato, D., Bertello, C., Garrone, C., Milan, A., Pagni, R., Veglio, F., & Mulatero, P. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.092080 · Cited by 107
Validity of the Aldosterone-Renin Ratio Used to Screen for Primary Aldosteronism
Montori, V. M., Schwartz, G. L., Chapman, A. B., Boerwinkle, E., & Turner, S. T. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.9.877 · Cited by 107 · cited 1×
“Because the ARR is mathematically highly dependent on renin (47), renin assays should be sufficiently sensitive to measure levels as low as 0.”
BackgroundPrimary Aldosteronism: Results of Surgical Treatment
Lo, C. Y., Tam, P. C., Kung, A. W. C., Lam, K. S. L., & Wong, J. (1996) · Annals of Surgery · doi:10.1097/00000658-199608000-00003 · Cited by 106 · cited 1×
“Hypertension is cured (defined as BP 140/90 mm Hg without the aid of antihypertensive drugs) in about 50% (range, 35–80%) of patients with APA after unilateral adrenalectomy (32, 38, 81, 161), with a “cure” rate as high as 56–77% when the cure threshold is BP 160/95 mm Hg (44, 166, 167), which is clearly still in the…”
BackgroundWu, V., Kuo, C., Wang, S., Liu, K., Huang, K., Lin, Y., Chu, T., Chang, H., Lin, C., Tsai, C., et al. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283495cbb · Cited by 106 · cited 3×
“Our recommendation also places a high value on avoiding the risk associated with missing a diagnosis of unilateral forms of PA and thus the opportunity of possibly curative intervention by unilateral adrenalectomy leading to the reduction or complete cessation of antihypertensive medications (39) and the reduction of…”
BackgroundBetz, M. J., Degenhart, C., Fischer, E., Pallauf, A., Brand, V., Linsenmaier, U., Beuschlein, F., Bidlingmaier, M., & Reincke, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0287 · Cited by 106
Self-citationMonticone, S., Satoh, F., Giacchetti, G., Viola, A., Morimoto, R., Kudo, M., Iwakura, Y., Ono, Y., Turchi, F., Paci, E., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.189548 · Cited by 105 · cited 1×
“Many groups advocate the use of continuous cosyntropin infusion during AVS to: 1) minimize stress-induced fluctuations in aldosterone secretion during nonsimultaneous (sequential) AVS; 2) maximize the gradient in cortisol from adrenal vein to inferior vena cava and thus confirm successful sampling of the adrenal vein…”
Hannemann, A., Bidlingmaier, M., Friedrich, N., Manolopoulou, J., Spyroglou, A., Volzke, H., Beuschlein, F., Seissler, J., Rettig, R., Felix, S. B., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1013 · Cited by 104 · cited 1×
“Cross-sectional and prospective studies report PA in (cid:2) 5% and possibly (cid:2) 10% of hypertensive patients, both in general and in specialty settings (6, 19–29).”
BackgroundSelf-citationRiester, A., Fischer, E., Degenhart, C., Reiser, M. F., Bidlingmaier, M., Beuschlein, F., Reincke, M., & Quinkler, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3789 · Cited by 102 · cited 1×
“However, the utility of these three criteria was not reproducible in two recently published studies (100, 102).”
BackgroundSelf-citationLin, Y., Lin, L., Chen, A., Wu, X.-M., Lee, J., Su, T., Wu, V., Chueh, S., Lin, W., Lo, M., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.003 · Cited by 101 · cited 1×
“Adrenalectomy also appears to reverse the increase in carotid intima-media thickness and arterial stiffness in patients with unilateral PA (34).”
BackgroundStowasser, M., & Gordon, R. D. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00097-8 · Cited by 101
Self-citationWolley, M. J., Gordon, R. D., Ahmed, A. H., & Stowasser, M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3676 · Cited by 100 · cited 1×
“The contralateral suppression of aldosterone secretion has recently been reported to be helpful in the diagnosis of unilateral PA (109, 110).”
BackgroundSelf-citationHolaj, R., Zelinka, T., Wichterle, D., Petrák, O., Štrauch, B., & Widimský, J. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281268532 · Cited by 99 · cited 1×
“fibrosis (150–152), increased carotid intima-media thickness (153, 154), and increased femoral pulse wave velocity and reduced endothelial function (155).”
BackgroundMineralocorticoid hypertension
Gordon, R. D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)93003-1 · Cited by 99
So, A., Duffy, D. L., Gordon, R. D., Jeske, Y. W., Lin-Su, K., New, M. I., & Stowasser, M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000174299.66369.26 · Cited by 98 · cited 1×
“Testing for familial forms of primary aldosteronism: familial hyperaldosteronism type II FH-II is an autosomal dominant disorder and possibly genetically heterogeneous (135).”
BackgroundSelf-citationAdrenalectomy Improves Arterial Stiffness in Primary Aldosteronism
Strauch, B., Petrak, O., Zelinka, T., Wichterle, D., Holaj, R., Kasalicky, M., Safarik, L., Rosa, J., & Widimsky, J. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.243 · Cited by 98 · cited 1×
“Researchers reported that arterial stiffness (measured as carotid-femoral pulse wave velocity and augmentation index) was reduced by unilateral adrenalectomy but not after 1 year of spironolactone treatment in PA (159).”
BackgroundGordon, R. D., Gómez-Sánchez, C. E., Hamlet, S. M., Tunny, T. J., & Klemm, S. A. (1987) · PubMed · Cited by 96
SARKAR, S. D., COHEN, E. L., BEIERWALTES, W. H., ICE, R. D., COOPER, R., & GOLD, E. N. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-2-353 · Cited by 96
Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood
Dluhy, R. G., Anderson, B. F., Harlin, B., Ingelfinger, J. R., & Lifton, R. P. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.112648 · Cited by 96
Primary Aldosteronism: Update on Diagnosis and Treatment
Young, W. F. (1997) · The Endocrinologist · doi:10.1097/00019616-199707040-00003 · Cited by 95
Self-citationSuccess of Surgery for Primary Aldosteronism Judged by Residual Autonomous Aldosterone Production
Rutherford, J. C., Taylor, W. L., Stowasser, M., & Gordon, R. D. (1998) · World Journal of Surgery · doi:10.1007/s002689900552 · Cited by 94
Self-citationNOMURA, K., KUSAKABE, K., MAKI, M., ITO, Y., AIBA, M., & DEMURA, H. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-825 · Cited by 92 · cited 1×
“However, the sensitivity of this test depends heavily on the size of the adenoma (119, 120).”
BackgroundConfirmatory Testing in Primary Aldosteronism
Nanba, K., Tamanaha, T., Nakao, K., Kawashima, S., Usui, T., Tagami, T., Okuno, H. G., Shimatsu, A., Suzuki, T., & Naruse, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2504 · Cited by 92 · cited 4×
“Nanba et al (60) performed a more complex evaluation”
BackgroundInfluentialFischer, E., Hanslik, G., Pallauf, A., Degenhart, C., Linsenmaier, U., Beuschlein, F., Bidlingmaier, M., Mussack, T., Ladurner, R., Hallfeldt, K. K. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2234 · Cited by 91 · cited 3×
“Persistent hypoaldosteron-ism requiring mineralocorticoid replacement therapy (fludrocortisone) may occur in up to 5% of adrenalectomized patients (176).”
BackgroundInfluentialSelf-citationComparison of Sequential versus Simultaneous Methods of Adrenal Venous Sampling
Carr, C. E., Cope, C., Cohen, D. L., Fraker, D. L., & Trerotola, S. O. (2004) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000134495.26900.6a · Cited by 91 · cited 1×
“Many groups advocate the use of continuous cosyntropin infusion during AVS to: 1) minimize stress-induced fluctuations in aldosterone secretion during nonsimultaneous (sequential) AVS; 2) maximize the gradient in cortisol from adrenal vein to inferior vena cava and thus confirm successful sampling of the adrenal vein…”
BackgroundLaboratory challenges in primary aldosteronism screening and diagnosis
Rehan, M., Raizman, J. E., Cavalier, E., Don-Wauchope, A. C., & Holmes, D. T. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.01.003 · Cited by 89 · cited 1×
“It should be noted that there is poor correlation between DRC and PRA in the range where PRA is 1 ng/mL/h, the domain of major interest in PA screening (221, 222).”
BackgroundAhmed, A. H., Gordon, R. D., Taylor, P. J., Ward, G., Pimenta, E., & Stowasser, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2918 · Cited by 89 · cited 12×
“A limitation of the ARR is that in the presence of very low renin levels (for example, at PRA values of 0.1 ng/ mL/h), the ARR may be elevated even when plasma aldosterone is also low (for example, 4 ng/dL or 110 pmol/L) and is almost certainly not consistent with PA.”
BackgroundInfluentialSelf-citationBurgess, E. D., Lacourcière, Y., Ruilope, L. M., Oparil, S., Kleiman, J. H., Krause, S. L., Roniker, B., & Maurath, C. J. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80282-5 · Cited by 87 · cited 1×
“hypertension (190, 191) in the United States and Japan,”
BackgroundRizzoni, D., Paiardi, S., Rodella, L., Porteri, E., De Ciuceis, C., Rezzani, R., Boari, G. E. M., Zani, F., Miclini, M., Tiberio, G. A. M., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0101 · Cited by 87 · cited 1×
“The pathophysiology was first established in animal models and subsequently was clearly demonstrated by several studies on PA patients (149).”
BackgroundFourkiotis, V., Vonend, O., Diederich, S., Fischer, E., Lang, K., Endres, S., Beuschlein, F., Willenberg, H. S., Rump, L. C., Allolio, B., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0631 · Cited by 85 · cited 1×
“Two prospective studies also reported the reversal of albuminuria 1 year after adrenalectomy (40, 168), and another study reported significant improvement in quality of life by 3 months sustained at 6 months (38).”
Self-citationPimenta, E., Gordon, R. D., Ahmed, A. H., Cowley, D., Leano, R., Marwick, T. H., & Stowasser, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0354 · Cited by 84
Self-citationThe incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981.
Andersen, G. S., Toftdahl, D. B., Lund, J., Strandgaard, S., & Nielsen, P. E. (1988) · PubMed · Cited by 81
Bystrom, C. E., Salameh, W., Reitz, R., & Clarke, N. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.146449 · Cited by 79 · cited 1×
“Assay reliability Clinicians can use an immunometric assay to measure renin either by testing for PRA or for direct renin concentration (DRC); tandem mass spectrometry methodology for measuring PRA has also been developed recently (46).”
MethodEffect of Age on Response of Secondary Hypertension to Specific Treatment
Streeten, D. H. P., Anderson, G. H., & Wagner, S. (1990) · American Journal of Hypertension · doi:10.1093/ajh/3.5.360 · Cited by 79 · cited 2×
“The duration of hypertension has been reported by several investigators to be a negative predictor of outcome after unilateral adrenalectomy for APA (44, 45), suggesting that delays in diagnosis may result in a poorer response to specific treatment once PA is finally diagnosed.”
BackgroundNakamura, Y., Satoh, F., Morimoto, R., Kudo, M., Takase, K., Gomez-Sanchez, C. E., Honma, S., Okuyama, M., Yamashita, K., Rainey, W. E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2785 · Cited by 78
High prevalence of autonomous aldosterone secretion among patients with essential hypertension
Gouli, A., Kaltsas, G., Τζώνου, Α., Markou, Α., Androulakis, I. I., Ragkou, D., Vamvakidis, K., Zografos, G., Kontogeorgos, G., Chrousos, G. P., et al. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02531.x · Cited by 77 · cited 1×
“The first is the dexamethasone-enhanced FST, whereby roughly 30% of referred hypertensives show PAC values above the range found in normotensive controls (72).”
BackgroundRutherford, J. C., Stowasser, M., Tunny, T. J., Klemm, S. A., & Gordon, R. D. (1996) · World Journal of Surgery · doi:10.1007/s002689900115 · Cited by 77
Self-citationSystemic Effects of Antihypertensive Agents.
(1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-5-708_7 · Cited by 76
IS ALDOSTERONE/RENIN RATIO USEFUL TO SCREEN A HYPERTENSIVE POPULATION FOR PRIMARY ALDOSTERONISM?
Hamlet, S. M., Tunny, T. J., Woodland, E., & Gordon, R. D. (1985) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1985.tb02641.x · Cited by 73
Marzano, L. A., Colussi, G., Sechi, L. A., & Catena, C. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu154 · Cited by 73 · cited 10×
“adrenal CT as the initial study in subtype testing to 1898 Funder et al Guidelines on Primary Aldosteronism J Clin Endocrinol Metab, May 2016, 101(5):1889–1916”
BackgroundMethodInfluentialDiagnosis of Secondary Forms of Hypertension: A Comprehensive Protocol
Grim, C. E. (1977) · JAMA · doi:10.1001/jama.1977.03270400035014 · Cited by 73
Webb, R., Mathur, A., Chang, R., Baid, S. K., Nilubol, N., Libutti, S. K., Stratakis, C. A., & Kebebew, E. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2121-5 · Cited by 72 · cited 3×
“Some investigators consider a cortisol-corrected aldosterone lateralization ratio (high to low side) of more than 2:1 in the absence of cosyntropin as consistent with unilateral disease (88, 104, 108).”
BackgroundCaptopril Test Can Give Misleading Results in Patients With Suspect Primary Aldosteronism
Mulatero, P., Bertello, C., Garrone, C., Rossato, D., Mengozzi, G., Verhovez, A., Fallo, F., & Veglio, F. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.093468 · Cited by 72 · cited 4×
“Finally, Willenberg et al (61) reported divergent results between the SIT and FST and also found a lower cutoff value for SIT than FST; this was in contrast with Mulatero et al (62, 63), who reported a satisfactory agreement be-tween the two tests.”
BackgroundResultInfluentialEndothelial Dysfunction Is Related to Aldosterone Excess and Raised Blood Pressure
Tsuchiya, K., Yoshimoto, T., & Hirata, Y. (2009) · Endocrine Journal · doi:10.1507/endocrj.k09e-014 · Cited by 71 · cited 1×
“fibrosis (150–152), increased carotid intima-media thickness (153, 154), and increased femoral pulse wave velocity and reduced endothelial function (155).”
BackgroundRay, J. A., Kushnir, M. M., Palmer, J., Sadjadi, S., Rockwood, A. L., & Meikle, A. W. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.08.042 · Cited by 71 · cited 1×
“The available RIAs for plasma aldosterone overestimate levels by 50– 100% in the range below 200 pmol/L, most probably from cross-reactivity with soluble aldosterone metabolites (49).”
BackgroundSelective Use of Adrenal Venous Sampling in the Lateralization of Aldosterone‐producing Adenomas
Tan, Y. Y., Ogilvie, J. B., Triponez, F., Caron, N. R., Kebebew, E. K., Clark, O. H., & Duh, Q. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0622-8 · Cited by 67
Hirohara, D. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4292 · Cited by 65 · cited 1×
“measurements (68, 69), Letavernier et al (70) consider PA”
Background
Research works printed but not linked: 3
- 15. Tucker RM, Labarthe DR. Frequency of surgical treatment for hypertensioninadultsattheMayoClinicfrom1973through1975. Mayo Clin Proc . 1977;52:549-545.
- 133. FardellaCE,PintoM,MossoL,Gómez-SánchezC,JalilJ,Montero J. Genetic study of patients with dexamethasone-suppressible aldosteronismwithoutthechimericCYP11B1/CYP11B2gene. J Clin Endocrinol Metab . 2001;86:4805-4807.
- 169. Jacobsen NE, Campbell JB, Hobart MG. Laparoscopic versus openadrenalectomyforsurgicaladrenaldisease. CanJUrol . 2003; 10:1995-1999.
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Self-citation2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Flynn, J. T., Kaelber, D. C., Baker-Smith, C. M., Blowey, D., Carroll, A. E., Daniels, S. R., de Ferranti, S. D., Dionne, J. M., Falkner, B., Flinn, S. K., et al. (2017) · Pediatrics · doi:10.1542/peds.2017-1904 · Cited by 3,651
Metadata
- Authors
- Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F.
- Affiliations
- Hudson Institute of Medical Research (AU)
- University of Virginia Health System (US)
- University of Padua (IT)
- Mayo Clinic (US)
- Klinikum of the Ludwig-Maximilians-University of Munich (M.R.), 80366 München, Bavaria, Germany
- Oita University (JP)
- The University of Queensland (AU)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-05-01
- Volume
- 101
- Issue
- 5
- Pages
- 1889-1916
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2290633895
- Semantic Scholar
- 36716f26ebd3b8e468f352d9132208c41e5688c0
- Cited by
- 2,925
- References
- 241
- Citations by year
- 2026: 236 · 2025: 397 · 2024: 315 · 2023: 329 · 2022: 329 · 2021: 315 · 2020: 293 · 2019: 238 · 2018: 200 · 2017: 188 · 2016: 72
- FWCI
- 233.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- primary aldosteronism, case finding, aldosterone-renin ratio, adrenal computed tomography, adrenal vein sampling, laparoscopic adrenalectomy, bilateral adrenal hyperplasia, mineralocorticoid receptor antagonists, hypertension, hypokalemia
- MeSH terms
- Adrenal Glands, Adrenalectomy, Aldosterone, Mineralocorticoid Receptor Antagonists, Humans, Hyperaldosteronism, Renin, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.